Loading...

Kim Hyung

Title(s)Associate Director, Samuel Oschin Cancer Institute
SchoolCedar-Sinai Medical Center
Phone310-423-4700
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kim HL, Puymon MR, Qin M, Guru K, Mohler JL. A method for using life tables to estimate lifetime risk for prostate cancer death. J Natl Compr Canc Netw. 2010 Feb; 8(2):148-54. PMID: 20141675.
      View in: PubMed
    2. Lam JS, Klatte T, Kim HL, Patard JJ, Breda A, Zisman A, Pantuck AJ, Figlin RA. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol. 2008 Mar; 65(3):235-62. PMID: 17931881.
      View in: PubMed
    3. Gore JL, Kim HL, Schulam P. Initial experience with laparoscopically assisted percutaneous cryotherapy of renal tumors. J Endourol. 2005 May; 19(4):480-3. PMID: 15910261.
      View in: PubMed
    4. Shvarts O, Lam JS, Kim HL, Belldegrun AS. Staging of renal cell carcinoma: current concepts. BJU Int. 2005 Mar; 95 Suppl 2:8-13. PMID: 15759349.
      View in: PubMed
    5. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004 Sep; 172(3):867-70. PMID: 15310985.
      View in: PubMed
    6. Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS. Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol. 2004 Sep-Oct; 22(5):410-4. PMID: 15464922.
      View in: PubMed
    7. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res. 2004 Aug 15; 10(16):5464-71. PMID: 15328185.
      View in: PubMed
    8. Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Mulders PF, Belldegrun AS. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004 Jun; 171(6 Pt 1):2181-5, quiz 2435. PMID: 15126781.
      View in: PubMed
    9. Kim HL, Han KR, Zisman A, Figlin RA, Belldegrun AS. Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. J Urol. 2004 May; 171(5):1810-3. PMID: 15076282.
      View in: PubMed
    10. Han KR, Kim HL, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun AS. Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma. Urology. 2004 May; 63(5):841-6; discussion 846-7. PMID: 15134960.
      View in: PubMed
    11. Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol. 2004 Feb; 171(2 Pt 1):588-91. PMID: 14713765.
      View in: PubMed
    12. Kim HL, Lam JS, Belldegrun AS. The role of lymphadenectomy in renal cell carcinoma. Curr Urol Rep. 2004 Feb; 5(1):25-9. PMID: 14733833.
      View in: PubMed
    13. Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. J Urol. 2003 Dec; 170(6 Pt 1):2221-4. PMID: 14634383.
      View in: PubMed
    14. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003 Nov; 30(4):843-52. PMID: 14680319.
      View in: PubMed
    15. Kim HL, Belldegrun AS, Freitas DG, Bui MH, Han KR, Dorey FJ, Figlin RA. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol. 2003 Nov; 170(5):1742-6. PMID: 14532767.
      View in: PubMed
    16. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, Kim HL, Lugg J, Childs SJ, Shuman B, Jayson MA, Shore ND, Moore Y, Zisman A, Lee JY, Ugarte R, Mynderse LA, Wilson TM, Sweat SD, Zincke H, Belldegrun AS. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003 Oct; 170(4 Pt 1):1126-30. PMID: 14501706.
      View in: PubMed
    17. Kim HL, Belldegrun AS, Figlin RA. Immune gene therapy for kidney cancer: the search for a magic trigger. Mol Ther. 2003 Feb; 7(2):153-4. PMID: 12597902.
      View in: PubMed
    Hyung's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Similar People
    People who share similar concepts with this person.
    _
    Same Department